Pharmaceutical News Roundup: Human Genome, Merck, Novartis

by | Nov 17, 2010 | Towing

Here’s a roundup of some of Wednesday’s major pharmaceutical news: An FDA panel gave Human Genome Sciences a boost with a thumbs-up for its lupus drug, Benlysta; Merck’s experimental heart drug appears to work well without side…

Novartis Discontinues Two Drug Development Programs

by | Oct 5, 2010 | Towing

Swiss pharmaceutical company Novartis announced Tuesday that it had discontinued the development of two drugs — the hepatitis C treatment Zalbin, and antifungal agent Mycograb. The company will take impairment charges of appro…